Please login to the form below

Not currently logged in
Email:
Password:

ERT

This page shows the latest ERT news and features for those working in and with pharma, biotech and healthcare.

Sangamo’s first gene-editing trial doesn’t convince investors

Sangamo’s first gene-editing trial doesn’t convince investors

these changes by conducting a controlled withdrawal of… ERT in patients enrolled in the study soon.”. ... Withdrawal from weekly ERT infusions would be “a very meaningful outcome”for patients with MPS II, he added.

Latest news

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Making good practice common practice in rare disease

    symptoms. Literature suggests fatigue may be the first symptom to significantly improve with enzyme replacement therapy (ERT), a key treatment for Gaucher Disease, but this critical factor may be overlooked when

  • ERT, Inc.

    ERT, Inc. ERT is passionate and committed about transforming the way you conduct your drug development and healthcare efforts.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Geoff
Cancer care – the power of new technologies
With patient numbers set to soar, how can we make a difference?...
image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...

Infographics